Across TCGA pan-cancer cohorts, HOXA5 RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated HOXA5 data layer compared with 3 for mutation status and 4 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher HOXA5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HOXA5 expression acts as an unfavorable survival marker, although some lineages such as ACC and COAD show a favorable association.
UCEC, CESC, and LGG are the cancer types where HOXA5 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.